Cradle Genomics -- the inventors of a novel prenatal testing methodology -- announced it closed $17.1 million in Series A funding.The post Cradle Genomics: This Non-Invasive Prenatal Testing Company Has Raised $17.1 Million appeared first on Pulse 2.0.